SAN DIEGO, Aug. 4, 2016 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AHS), healthcare's leader and innovator in workforce solutions and staffing services, today announced its second-quarter 2016 financial results, which exceeded the Company's guidance. Financial highlights are as follows:

Dollars in millions, except per share amounts.



              Q2 2016        % Change     YTD June 30,          % change
                                                        2016   YTD June 30,
                              Q2 2015                                       2015
                              -------                                       ----

    Revenue           $473.7          35%              $941.7                  39%
    -------           ------          ---               ------                  ---

     Gross
     profit           $154.8          41%              $306.7                  45%
     ------           ------          ---               ------                  ---

    Net
     income            $26.3          66%               $52.2                  86%
    -------            -----          ---                -----                  ---

     Diluted
     EPS               $0.53          66%               $1.06                  83%
     -------           -----          ---                -----                  ---

     Adjusted
     diluted
     EPS*              $0.61          61%               $1.20                  74%
     --------          -----          ---                -----                  ---

     Adjusted
     EBITDA*           $59.3          50%              $117.9                  62%
     --------          -----          ---               ------                  ---


    *  See "Non-GAAP Measures" below
     for a discussion of our use of
     non-GAAP items and the table
     entitled "Supplemental Financial
     and Operating Data" for a
     reconciliation of non-GAAP items.

Second-Quarter 2016 Highlights


    --  Revenue grew 35% year-over-year driven by 19% organic growth and the
        remainder from acquisitions.
    --  Solid demand and operating metrics continued throughout the quarter,
        with the strongest growth in the Nurse and Allied Solutions segment.
    --  Net income of $26.3 million was 66% higher year-over-year and adjusted
        EBITDA margin was 12.5%, reflecting a 130 basis point increase
        year-over-year, driven by gross margin expansion.
    --  Diluted EPS of $0.53 grew 66% and adjusted diluted EPS of $0.61 grew 61%
        year-over-year.
    --  The acquisition of Peak Health Solutions, completed in June 2016,
        expands AMN's service offerings into medical coding and consulting.

"The AMN Healthcare team delivered another record quarter of revenue and earnings due to a strong market environment and tremendous execution to address our client's critical and evolving workforce needs. In addition to the strong demand for staffing and placement services, we continue to increase the penetration of our workforce solutions, in particular MSP, VMS and workforce optimization services," said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. "The desire to build strategic partnerships and rising level of sophistication within healthcare creates great opportunity for AMN to partner with our clients to deliver cost effective, quality patient care."

Second-Quarter 2016 Results

Consolidated revenue was $474 million, an increase of 35% from the same quarter last year, driven by 19% organic growth; revenue increased 1% sequentially. Revenue for the Nurse and Allied Solutions segment was $293 million, an increase of 29% from the same quarter last year and down 2% sequentially. Locum Tenens Solutions revenue was $109 million, an increase of 12% from the same quarter last year and 6% sequentially. Other Workforce Solutions segment revenue was $72 million, an increase of 174% from the same quarter last year and 7% sequentially. The Other Workforce Solutions segment revenue grew 32% organically from the prior year with the remainder from recent acquisitions.

Gross margin was 32.7%, which is 130 basis points higher than the same quarter last year and 20 basis points higher sequentially. The year-over-year gross margin improvement continues to be primarily driven by growth in the higher-margin Other Workforce Solutions segment, along with a gross margin increase in the Locum Tenens Solution segment.

SG&A expenses were $100 million, or 21.0% of revenue, compared to $75 million, or 21.3% of revenue, in the same quarter last year and $98 million, or 20.9% of revenue, in the previous quarter. The 30 basis point decline in percentage of revenue year-over-year was driven by operating leverage.

Net income was $26 million, or $0.53 per diluted share. Excluding amortization of intangible assets and acquisition and integration costs, net of tax, adjusted net income per diluted share was $0.61. Adjusted EBITDA was $59 million, a year-over-year increase of 50%. Adjusted EBITDA margin was 12.5%, representing a 130 basis point increase year-over-year and flat sequentially.

At June 30, 2016, cash and cash equivalents totaled $21 million. Cash flow from operations was $20 million and capital expenditures were $6 million. The Company ended the quarter with total debt outstanding of $413 million, with a leverage ratio as calculated in accordance with our credit agreement of 1.9 to 1.

Third-Quarter 2016 Outlook



                    Metric                             Guidance*
                    ------                              --------

             Consolidated revenue                           $466 - $472 MM
             --------------------                           --------------

                 Gross margin                                32.5% - 33.0%
                 ------------                                 ------------

        SG&A as percentage of revenue                                21.5%
        -----------------------------                                 ----

            Adjusted EBITDA margin                           11.5% - 12.0%
            ----------------------                            ------------


    *Note: Guidance percentage metrics
     are approximate. For a
     reconciliation of Adjusted EBITDA
     margin, see the table entitled
     "Reconciliation of Guidance
     Adjusted EBITDA Margin to Guidance
     Operating Margin" below.

The Company's revenue guidance is based on the expectation of a continued strong demand environment, representing year-over-year growth of approximately 22%.

Conference Call on August 4, 2016

AMN Healthcare Services, Inc. (NYSE: AHS), healthcare's leader and innovator in workforce solutions and staffing services, will host a conference call to discuss its second-quarter 2016 financial results on Thursday, August 4, 2016 at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9960 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company's website. Alternatively, a telephonic replay of the call will be available starting at 7:30 p.m. Eastern Time on August 4, 2016, and can be accessed until 11:59 p.m. Eastern Time on August 18, 2016 by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 397211.

About AMN Healthcare

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN delivers managed services programs, healthcare executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, medical coding and consulting, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities and many other healthcare settings.

The Company's common stock is listed on the New York Stock Exchange under the symbol "AHS." For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication ("RSS") as routine channels to supplement distribution of this information. To register for email alerts and RSS, visit http://amnhealthcare.investorroom.com/emailalerts.

Non-GAAP Measures

This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company's condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin and (3) adjusted diluted EPS. The Company provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company's operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP measures and may be different from non-GAAP measures, or may be calculated differently than other similarly title-captioned non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company's performance. A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled "Supplemental Financial and Operating Data" under the caption entitled "Reconciliation of Non-GAAP Items," the table entitled, "Reconciliation of Guidance Adjusted EBITDA Margin to Guidance Operating Margin," and the footnotes thereto or on the Company's website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company's website.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding the outlook for 2016, the favorable demand environment, third-quarter 2016 revenue, gross margin, SG&A expenses and adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may," "estimates," variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 and its other periodic reports as well as the Company's current and other reports filed from time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated.

Contact:
David Erdman
Director, Investor Relations
866.861.3229


                                                              AMN Healthcare Services, Inc.

                                                Condensed Consolidated Statements of Comprehensive Income

                                                        (in thousands, except per share amounts)

                                                                       (unaudited)


                                                                                                          Three Months Ended Six Months Ended
                                                                                                          ------------------ ----------------

                                                                                                               June 30,                        March 31,          June 30,
                                                                                                               --------                                           --------

                                                                                                                        2016              2015               2016              2016      2015
                                                                                                                        ----              ----               ----              ----      ----

    Revenue                                                                                                         $473,729          $350,144           $468,002          $941,731  $677,654

    Cost of revenue                                                                                                  318,976           240,026            316,104           635,080   466,104
                                                                                                                     -------           -------            -------           -------   -------

    Gross profit                                                                                                     154,753           110,118            151,898           306,651   211,550
                                                                                                                     -------           -------            -------           -------   -------

          Gross margin                                                                                                 32.7%            31.4%             32.5%            32.6%    31.2%

    Operating expenses:

    Selling, general and
     administrative (SG&A)                                                                                            99,541            74,727             97,823           197,364   146,279

    SG&A as a % of revenue                                                                                             21.0%            21.3%             20.9%            21.0%    21.6%


    Depreciation and
     amortization                                                                                                      7,334             5,232              6,765            14,099    10,327
                                                                                                                       -----             -----              -----            ------    ------

    Total operating
     expenses                                                                                                        106,875            79,959            104,588           211,463   156,606
                                                                                                                     -------            ------            -------           -------   -------

    Income from operations                                                                                            47,878            30,159             47,310            95,188    54,944

    Operating margin (1)                                                                                               10.2%             8.6%             10.2%            10.1%     8.1%


    Interest expense, net,
     and other                                                                                                         2,800             1,977              3,249             6,049     3,784
                                                                                                                       -----             -----              -----             -----     -----

    Income before income
     taxes                                                                                                            45,078            28,182             44,061            89,139    51,160

    Income tax expense                                                                                                18,756            12,312             18,192            36,948    23,081
                                                                                                                      ------            ------             ------            ------    ------

    Net income                                                                                                       $26,322           $15,870            $25,869           $52,191   $28,079
                                                                                                                     -------           -------            -------           -------   -------

    Net income as a % of
     revenue                                                                                                            5.6%             4.5%              5.6%             5.6%     4.1%


    Other comprehensive income (loss):

    Foreign currency
     translation                                                                                                          86              (80)                39               125      (12)

    Unrealized gain (loss)
     on cash flow hedge,
     net of income taxes                                                                                               (111)               36              (463)            (574)       36
                                                                                                                        ----               ---               ----              ----       ---

    Other comprehensive
     income (loss)                                                                                                      (25)             (44)             (424)            (449)       24

    Comprehensive income                                                                                             $26,297           $15,826            $25,445           $51,742   $28,103
                                                                                                                     -------           -------            -------           -------   -------

    Net income per common share:

    Basic                                                                                                              $0.55             $0.33              $0.54             $1.09     $0.59
                                                                                                                       -----             -----              -----             -----     -----

    Diluted                                                                                                            $0.53             $0.32              $0.53             $1.06     $0.58
                                                                                                                       -----             -----              -----             -----     -----


    Weighted average common shares outstanding:

    Basic                                                                                                             48,034            47,573             47,894            47,964    47,361
                                                                                                                      ------            ------             ------            ------    ------

    Diluted                                                                                                           49,348            48,863             49,103            49,225    48,615
                                                                                                                      ------            ------             ------            ------    ------



                                                    AMN Healthcare Services, Inc.

                                              Supplemental Financial and Operating Data

                                            (dollars in thousands, except per share data)

                                                             (unaudited)


                                                     Three Months Ended                    Six Months Ended
                                                     ------------------                    ----------------

                                             June  30,                         March 31,                    June 30,
                                             ---------                         ---------                    --------

                                              2016                     2015 (2)                                 2016            2016             2015 (2)

    Revenue

      Nurse and allied solutions                       $292,663                     $226,494                           $297,724         $590,387              $443,486

      Locum tenens solutions                          109,129                       97,388                            102,738          211,867               184,080

      Other workforce solutions                        71,937                       26,262                             67,540          139,477                50,088

                                                       $473,729                     $350,144                           $468,002         $941,731              $677,654



    Reconciliation of Non-GAAP Items:


    Segment operating income (3)

      Nurse and allied solutions                        $39,503                      $31,159                            $41,618          $81,121               $58,521

      Locum tenens solutions                           16,317                       11,711                             13,291           29,608                20,821

      Other workforce solutions                        17,858                        7,513                             17,586           35,444                15,323

                                                       73,678                       50,383                             72,495          146,173                94,665

       Unallocated corporate overhead                  14,420                       11,006                             13,805           28,225                21,966
                                                       ------                       ------                             ------           ------                ------

    Adjusted EBITDA (4)                                59,258                       39,377                             58,690          117,948                72,699

    Adjusted EBITDA margin (5)                          12.5%                       11.2%                             12.5%           12.5%                10.7%


    Depreciation and amortization                       7,334                        5,232                              6,765           14,099                10,327

    Share-based compensation                            2,710                        2,153                              3,381            6,091                 4,530

    Acquisition and integration costs                   1,336                        1,833                              1,234            2,570                 2,898
                                                        -----                        -----                              -----            -----                 -----

    Income from operations                             47,878                       30,159                             47,310           95,188                54,944

    Interest expense, net, and other                    2,800                        1,977                              3,249            6,049                 3,784
                                                        -----                        -----                              -----            -----                 -----

    Income before income taxes                         45,078                       28,182                             44,061           89,139                51,160

    Income tax expense                                 18,756                       12,312                             18,192           36,948                23,081
                                                       ------                       ------                             ------           ------                ------

    Net income                                          $26,322                      $15,870                            $25,869          $52,191               $28,079




    GAAP diluted net income per share (EPS)               $0.53                        $0.32                              $0.53            $1.06                 $0.58

       Adjustments:

       Amortization of intangible assets                 0.09                         0.06                               0.09             0.18                  0.12

       Acquisition and integration costs                 0.03                         0.04                               0.03             0.05                  0.06

       Tax effect of adjustments                       (0.04)                      (0.04)                            (0.05)          (0.09)               (0.07)

    Adjusted diluted EPS (6)                              $0.61                        $0.38                              $0.60            $1.20                 $0.69



                                                                      Three Months Ended                                    Six Months Ended
                                                                      ------------------                                    ----------------

                                                                             June 30,                             March 31,                          June 30,
                                                                             --------                             ---------                          --------

                                                                                      2016                   2015                               2016              2016      2015

    Gross Margin

       Nurse and allied solutions                                                    26.7%                 27.2%                             26.6%            26.7%    26.9%

       Locum tenens solutions                                                        31.3%                 29.2%                             31.0%            31.1%    29.3%

       Other workforce solutions                                                     58.9%                 76.0%                             60.3%            59.6%    76.3%


    Operating Data:
    ---------------

    Nurse and allied solutions

    Average healthcare professionals on assignment (7)                               8,337                  7,227                              8,474             8,406     7,225

    Revenue per healthcare professional per day (8)                                   $386                   $344                               $386              $386      $339

    Locum tenens solutions

        Days filled (9)                                                             61,068                 59,844                             58,166           119,234   114,104

        Revenue per day filled (10)                                                 $1,787                 $1,627                             $1,766            $1,777    $1,613



                                                       As of June 30,                      As of March 31,
                                                       --------------                      ---------------

                                                                                      2016                   2015                               2016

    Leverage ratio (11)                                                                1.9                    1.9                                1.9


                                             AMN Healthcare Services, Inc.

                                         Condensed Consolidated Balance Sheets

                                                (dollars in thousands)

                                                      (unaudited)


                                         June 30,                              March 31,          December 31,

                                                      2016                                   2016                  2015
                                                      ----                                   ----                  ----

    Assets

    Current assets:

    Cash and cash equivalents                      $21,062                                $23,106                $9,576

    Accounts receivable, net                       330,853                                302,342               277,996

    Accounts receivable,
     subcontractor                                  46,326                                 49,858                50,807

    Prepaid and other current
     assets                                         44,332                                 37,656                37,249
                                                    ------                                 ------                ------

    Total current assets                           442,573                                412,962               375,628

    Restricted cash and cash
     equivalents                                    28,490                                 27,176                27,352

    Fixed assets, net                               56,575                                 53,731                50,134

    Other assets                                    54,759                                 52,993                47,569

    Goodwill                                       342,827                                307,161               204,779

    Intangible assets, net                         255,214                                240,478               174,970
                                                   -------                                -------               -------


    Total assets                                $1,180,438                             $1,094,501              $880,432
                                                ----------                             ----------              --------


    Liabilities and stockholders' equity

    Current liabilities:

    Accounts payable and
     accrued expenses                             $131,965                               $109,121              $118,822

    Accrued compensation and
     benefits                                      102,516                                 98,049                83,701

    Current portion of
     revolving credit
     facility                                       40,000                                 40,000                30,000

    Current portion of notes
     payable                                        11,250                                 11,250                 7,500

    Deferred revenue                                 6,145                                  8,436                 5,620

    Other current liabilities                        9,728                                 23,998                 5,374
                                                     -----                                 ------                 -----

    Total current liabilities                      301,604                                290,854               251,017



    Revolving credit facility                      166,500                                127,500                52,500

    Notes payable, less
     unamortized fees                              194,019                                196,746               128,490

    Deferred income taxes,
     net                                            30,921                                 22,514                22,431

    Other long-term
     liabilities                                    84,495                                 83,076                78,134
                                                    ------                                 ------                ------

    Total liabilities                              777,539                                720,690               532,572


    Commitments and contingencies


    Stockholders' equity                           402,899                                373,811               347,860
                                                   -------                                -------               -------


    Total liabilities and
     stockholders' equity                       $1,180,438                             $1,094,501              $880,432
                                                ----------                             ----------              --------


                                AMN Healthcare Services, Inc.

                   Summary Condensed Consolidated Statements of Cash Flows

                                    (dollars in thousands)

                                         (unaudited)


                                     Three Months Ended                               Six Months Ended
                                   ------------------                           ----------------

                                   June 30,                           March 31,                          June 30,
                                   --------                                                              --------

                                   2016            2015                      2016                      2016            2015
                                   ----            ----                      ----                      ----            ----


    Net cash
     provided by
     operating
     activities                 $20,053         $25,000                   $35,227                   $55,280         $33,687


    Net cash  used
     in investing
     activities                (58,451)        (9,516)                (174,703)                (233,154)       (94,866)


    Net cash
     provided by
     (used in)
     financing
     activities                  36,268        (12,563)                  152,967                   189,235          62,592


    Effect of
     exchange
     rates on cash                   86            (80)                       39                       125            (12)
                                    ---             ---                       ---                       ---             ---


    Net increase
     (decrease) in
     cash and cash
     equivalents                (2,044)          2,841                    13,530                    11,486           1,401

    Cash and cash
     equivalents
     at beginning
     of period                   23,106          11,633                     9,576                     9,576          13,073
                                 ------          ------                     -----                     -----          ------


    Cash and cash
     equivalents
     at end of
     period                     $21,062         $14,474                   $23,106                   $21,062         $14,474
                                -------         -------                   -------                   -------         -------


                                                 AMN Healthcare Services, Inc.

                                          Additional Supplemental Non-GAAP Disclosures

                                      Reconciliation of Guidance Adjusted EBITDA Margin to

                                                   Guidance Operating Margin

                                                          (unaudited)


                                                                           Three Months Ending
                                                                           -------------------

                                                                           September 30, 2016
                                                                           ------------------

                                                                                   Low              High
                                                                                   ---              ----

    Adjusted EBITDA margin                                                               11.5%           12.0%

    Deduct:

    Share-based compensation                                                                   0.6%

    Acquisition and integration costs                                                          0.2%

    EBITDA margin                                                                        10.7%           11.2%
                                                                                          ----             ----

    Depreciation and amortization                                                              1.7%

    Operating margin                                                                      9.0%            9.5%
                                                                                           ===              ===



                (1)    Operating margin represents income
                        from operations divided by revenue.


                (2)    Effective as of January 1, 2016, we
                        modified our reportable segments.
                        We previously utilized three
                        reportable segments, which we
                        identified as follows: (a) nurse
                        and allied healthcare staffing, (b)
                        locum tenens staffing, and (c)
                        physician permanent placement
                        services. In light of our
                        acquisitions over the past several
                        years as well as our transition to
                        a healthcare workforce solutions
                        company, our management renamed our
                        three reportable segments and also
                        placed several of our business
                        lines that were in our nurse and
                        allied healthcare staffing segment
                        into a different segment to better
                        reflect how the business is
                        evaluated by our chief operating
                        decision maker. As of January 1,
                        2016, we began to disclose the
                        following three reportable
                        segments: (a) nurse and allied
                        solutions, (b) locum tenens
                        solutions, and (c) other workforce
                        solutions. The nurse and allied
                        solutions segment includes our
                        nurse, allied, and local staffing
                        businesses. The locum tenens
                        solutions segment includes our
                        locum tenens staffing business. The
                        other workforce solutions segment
                        includes our healthcare interim
                        leadership staffing and executive
                        search services business, physician
                        permanent placement services
                        business, recruitment process
                        outsourcing business, vendor
                        management systems business,
                        workforce optimization services
                        business, medical coding and
                        consulting business, and education
                        business. Prior period data has
                        been reclassified to conform to the
                        new segment reporting structure.


                (3)    Segment operating income represents
                        net income plus interest expense
                        (net of interest income) and other,
                        income tax expense, depreciation
                        and amortization, unallocated
                        corporate overhead, acquisition and
                        integration costs and share-based
                        compensation.


                (4)    Adjusted EBITDA represents net
                        income plus interest expense (net
                        of interest income) and other,
                        income tax expense, depreciation
                        and amortization, acquisition and
                        integration costs and share-based
                        compensation. Management believes
                        that adjusted EBITDA provides an
                        effective measure of the Company's
                        results, as it excludes certain
                        items that management believes are
                        not indicative of the Company's
                        operating performance and is a
                        measure used in credit facilities.
                        Adjusted EBITDA is not intended to
                        represent cash flows for the
                        period, nor has it been presented
                        as an alternative to income from
                        operations or net income as an
                        indicator of operating performance.
                        Although management believes that
                        some of the items excluded from
                        adjusted EBITDA are not indicative
                        of the Company's operating
                        performance, these items do impact
                        the statement of comprehensive
                        income, and management therefore
                        utilizes adjusted EBITDA as an
                        operating performance measure in
                        conjunction with GAAP measures such
                        as net income.


                (5)    Adjusted EBITDA margin represents
                        adjusted EBITDA divided by revenue.


                (6)    Adjusted diluted EPS represents GAAP
                        diluted EPS excluding the impact of
                        1) amortization of intangible
                        assets, 2) acquisition and
                        integration costs, and 3) tax
                        effect net of adjustments.
                        Management included this non-GAAP
                        measure to provide investors and
                        prospective investors with an
                        alternative method for assessing
                        the Company's operating results in
                        a manner that is focused on its
                        operating performance and to
                        provide a more consistent basis for
                        comparison between periods.
                        However, investors and prospective
                        investors should note that this
                        non-GAAP measure involves judgment
                        by management (in particular,
                        judgment as to what is classified
                        as a special item to be excluded
                        from adjusted diluted EPS).
                        Although management believes the
                        items excluded from adjusted
                        diluted EPS are not indicative of
                        the Company's operating
                        performance, these items do impact
                        the statement of comprehensive
                        income, and management therefore
                        utilizes adjusted diluted EPS as an
                        operating performance measure in
                        conjunction with GAAP measures such
                        as GAAP diluted EPS.


                (7)    Average healthcare professionals on
                        assignment represents the average
                        number of nurse and allied
                        healthcare professionals on
                        assignment during the period
                        presented.


                (8)    Revenue per healthcare professional
                        per day represents the revenue of
                        the Company's nurse and allied
                        solutions segment divided by
                        average healthcare professionals on
                        assignment, divided by the number
                        of days in the period presented.


                (9)    Days filled is calculated by
                        dividing the locum tenens hours
                        filled during the period by eight
                        hours.


               (10)    Revenue per day filled represents
                        revenue of the Company's locum
                        tenens solutions segment divided by
                        days filled for the period
                        presented.


               (11)    Leverage ratio represents the ratio
                        of the consolidated funded
                        indebtedness (as calculated per the
                        Company's credit agreement) at the
                        end of the subject period to the
                        consolidated adjusted EBITDA (as
                        calculated per the Company's credit
                        agreement) for the twelve month
                        period ending at the end of the
                        subject period.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amn-healthcare-announces-second-quarter-2016-results-300309588.html

SOURCE AMN Healthcare Services, Inc.